Increased risk of myocardial infarction associated with angiotensin-converting enzyme gene polymorphism is age dependent

Journal of Clinical Pharmacology

Volumn 51, Issue 9, 2011, Pages 1286-1292

  Hamelin, Bettina A ^a   Zakrzewski Jakubiak, Marcin ^b   Robitaille, N Michelle ^a   Bogaty, Peter ^a   Labbé, Line ^b   Turgeon, Jacques ^b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

ACE I D; age dependent; Myocardial infarction; polymorphism

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DNA POLYMORPHISM; ENZYME ACTIVITY; GENE FREQUENCY; GENETIC PREDISPOSITION; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; AGING; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; MIDDLE AGED; MUTAGENESIS, INSERTIONAL; MYOCARDIAL INFARCTION; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RISK FACTORS; SEQUENCE DELETION; YOUNG ADULT;

EID: 80051730972     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270010382420     Document Type: Article

References (34)

1. Talbert RL Pharmacotherapy: A Pathophysiologic Approach. 6 th ed.New York: Elsevier; 2005:219-250. DiPiro JT Talbert RL Yee GC, ed. New York: Elsevier ; 2005: 219-250.
2. Caulfield M, Newell-Price J. The angiotensin converting enzyme gene in cardiovascular disease. Br Heart J. 1995 ; 74: 207-208
3. Raynolds MV, Perryman MB. The association between the angiotensin I converting enzyme gene polymorphism and cardiovascular disease. Coron Artery Dis. 1995 ; 6: 302-309
4. Erdos EG. Angiotensin I converting enzyme. Circ Res. 1975 ; 36: 247-255
5. Peach MJ. Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev. 1977 ; 57: 313-370 (Pubitemid 8097628)
6. Dzau VJ. Tissue renin-angiotensin system in myocardial hypertrophy and failure. Arch Intern Med. 1993 ; 153: 937-942 (Pubitemid 23124734)
7. Dzau VJ. Vascular renin-angiotensin system and vascular protection. J Cardiovasc Pharmacol. 1993 ; 22 (suppl 5). S1 - S9
8. Schelling P, Fischer H, Ganten D. Angiotensin and cell growth: a link to cardiovascular hypertrophy?. J Hypertens. 1991 ; 9: 3-15
9. Hanna IR, Taniyama Y, Szocs K, Rocic P, Griendling KK. NAD(P)H oxidase-derived reactive oxygen species as mediators of angiotensin II signaling. Antioxid Redox Signal. 2002 ; 4: 899-914 (Pubitemid 36042466)
10. Schulman IH, Zhou MS, Raij L. Nitric oxide, angiotensin II, and reactive oxygen species in hypertension and atherogenesis. Curr Hypertens Rep. 2005 ; 7: 61-67 (Pubitemid 40277791)
11. Powell JS, Clozel JP, Muller RK, et al. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science. 1989 ; 245: 186-188 (Pubitemid 19193936)
12. Aberg G, Ferrer P. Effects of captopril on atherosclerosis in cynomolgus monkeys. J Cardiovasc Pharmacol. 1990 ; 15 (suppl 5). S65 - S72
13. Rakugi H, Wang DS, Dzau VJ, Pratt RE. Potential importance of tissue angiotensin-converting enzyme inhibition in preventing neointima formation. Circulation. 1994 ; 90: 449-455 (Pubitemid 24203711)
14. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement Trial. The SAVE Investigators. N Engl J Med. 1992 ; 327: 669-677
15. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 1992 ; 327: 685-691
16. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000 ; 342: 145-153
17. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990 ; 86: 1343-1346 (Pubitemid 20370444)
18. Tiret L, Rigat B, Visvikis S, et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet. 1992 ; 51: 197-205
19. Cambien F, Poirier O, Lecerf L, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992 ; 359: 641-644
20. Tiret L, Ducimetiere P, Bonnardeaux A, et al. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet. 1994 ; 344: 910-913 (Pubitemid 24295876)
21. Cambien F, Costerousse O, Tiret L, et al. Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation. 1994 ; 90: 669-676 (Pubitemid 24242731)
22. Fujisawa T, Ikegami H, Shen GQ, et al. Angiotensin I-converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM. Diabetes Care. 1995 ; 18: 983-985
23. Lindpaintner K, Pfeffer MA, Kreutz R, et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med. 1995 ; 332: 706-711
24. Friedl W, Krempler F, Paulweber B, Pichler M, Sandhofer F. A deletion polymorphism in the angiotensin converting enzyme gene is not associated with coronary heart disease in an Austrian population. Atherosclerosis. 1995 ; 112: 137-143
25. Anderson JL, Carlquist JF, King GJ, et al. Angiotensin-converting enzyme genotypes and risk for myocardial infarction in women. J Am Coll Cardiol. 1998 ; 31: 790-796 (Pubitemid 28186412)
26. Espinosa JS, Rueda E, Munoz E, et al. Association between myocardial infarction and angiotensin converting enzyme gene polymorphism in young patients. Med Clin (Barc). 1998 ; 110: 488-491 (Pubitemid 128530179)
27. Samani NJ, Thompson JR, O'Toole L, Channer K, Woods KL. A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation. 1996 ; 94: 708-712 (Pubitemid 26289226)
28. Keavney B, McKenzie C, Parish S, et al. Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. Lancet. 2000 ; 355: 434-442 (Pubitemid 30085151)
29. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res. 1992 ; 20: 1433
30. Fogarty DG, Maxwell AP, Doherty CC, Hughes AE, Nevin NC. ACE gene typing. Lancet. 1994 ; 343: 851
31. Zhao Y HJ, Kamitani A, Miki T, Mikami H, Ogihara T. Significance of deletion polymorphism of the ACE gene as a risk factor for myocardial infarction in Japanese. J Hypertens. 1994 ; 12: S71
32. Ruiz J, Blanche H, Cohen N, et al. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A. 1994 ; 91: 3662-3665 (Pubitemid 24139491)
33. Marian AJ, Yu QT, Workman R, Greve G, Roberts R. Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet. 1993 ; 342: 1085-1086 (Pubitemid 23338741)
34. Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profiles. Am Heart J. 1991 ; 121: 293-298